Doctor profile · Federal record
Dr. Kristen Luzzi, P.A.-C.
Medical Physician Assistant (CMS: Physician Assistant) · Linden, NJ
- NPI 1235487737
- Accepts Medicare
- MIPS 77.9 / 100 · 2023
- 14 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
515 N Wood Ave
Linden, NJ 070364173
(908) 925-8877
fax (908) 925-4164
Credentials & registration
- NPI registered
- August 2012 — 14 yrs on file
- Profile last updated
- October 28, 2014
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 363AM0700X — NUCC code
- State license (1)
- New Jersey #25MP00290500
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1235487737. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,453
Distinct HCPCS
10
Medicare allowed
$77,564
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 497 | 90 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 306 | 231 | $84 | |
17000 |
Destruction of precancer skin growth, 1 growth | 180 | 118 | $48 | |
17110 |
Destruction of skin growth, 1-14 growths | 127 | 98 | $106 | |
11102 |
Biopsy of related skin growth, first growth | 111 | 101 | $85 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 54 | 54 | $104 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 36 | 30 | $54 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 34 | 19 | $120 | |
11103 |
Biopsy of related skin growth, each additional growth | 30 | 22 | $49 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 28 | 18 | $1 |
In context: peer comparison
Among 1 peers in Linden Medical Physician Assistant, average services per provider: 111. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$2,435
Transactions
148
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Incyte Corporation | 19 | $273.67 | |
| Janssen Biotech, INC. | 11 | $241.55 | |
| Dermavant Sciences, INC. | 16 | $215.44 | |
| Abbvie INC. | 15 | $187.19 | |
| Leo Pharma INC. | 15 | $186.66 | |
| Arcutis Biotherapeutics, INC. | 14 | $179.04 | |
| Pfizer INC. | 5 | $159.31 | |
| Ucb, INC. | 9 | $140.80 | |
| Amgen INC. | 9 | $139.14 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 9 | $132.78 | |
| Sun Pharmaceutical Industries INC. | 6 | $103.86 | |
| Mayne Pharma Commercial LLC | 7 | $84.44 | |
| Lilly USA, LLC | 5 | $79.98 | |
| Galderma Laboratories, L.P. | 4 | $67.90 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $64.60 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
250
Patients
148
Total drug cost
$6,477
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 48 | 30 | $483 |
| Ketoconazole | Generic | 41 | 29 | $768 |
| Hydrocortisone | Generic | 36 | 26 | $241 |
| Fluocinonide | Generic | 35 | 26 | $1,840 |
| Clobetasol Propionate | Generic | 32 | 23 | $2,035 |
| Mupirocin | Generic | 17 | 14 | $109 |
| Clindamycin Phosphate | Generic | 16 | 0 | $488 |
| Ammonium Lactate | Generic | 13 | 0 | $293 |
| Doxycycline Hyclate | Generic | 12 | 0 | $220 |
Frequently asked questions
What is Dr. Kristen Luzzi's medical specialty?
Dr. Kristen Luzzi practices Medical Physician Assistant in Linden, NJ.
Where does Dr. Kristen Luzzi practice?
Dr. Kristen Luzzi practices at 515 N Wood Ave, Linden, NJ 070364173. Office phone: 9089258877.
What is Dr. Kristen Luzzi's NPI?
Dr. Kristen Luzzi's National Provider Identifier (NPI) is 1235487737, issued by NPPES.
Does Dr. Kristen Luzzi accept Medicare assignment?
Yes. Dr. Kristen Luzzi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kristen Luzzi commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.